loading

Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten

pulisher
Nov 25, 2025

Maxim Group Reaffirms Buy on Medicus Pharma Ltd (MDCX) With $20 Target - Insider Monkey

Nov 25, 2025
pulisher
Nov 24, 2025

13 Best Canadian Penny Stocks to Buy Right Now - Insider Monkey

Nov 24, 2025
pulisher
Nov 24, 2025

Small cap wrap: Medicus Pharma, Century Lithium, Aftermath Silver, Northstar Gold, First Phosphate… - Proactive financial news

Nov 24, 2025
pulisher
Nov 24, 2025

Medicus Pharma explores novel treatment innovations for prostate, skin cancers - TipRanks

Nov 24, 2025
pulisher
Nov 24, 2025

Medicus Pharma spotlights new approaches to prostate and skin cancer during Men’s Health Awareness Month - Proactive financial news

Nov 24, 2025
pulisher
Nov 24, 2025

Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers - The Manila Times

Nov 24, 2025
pulisher
Nov 24, 2025

Medicus Pharma Ltd. Explore Novel Treatment Innovations - GlobeNewswire

Nov 24, 2025
pulisher
Nov 22, 2025

Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The Florida Times-Union

Nov 22, 2025
pulisher
Nov 21, 2025

Medicus Pharma files to sell 2.68M common shares for holders - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

How buybacks impact Medicus Pharma Ltd. stock value2025 Price Momentum & Expert Approved Trade Ideas - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why Medicus Pharma Ltd. (N460) stock attracts HNW investorsIPO Watch & Low Drawdown Investment Strategies - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

What drives Medicus Pharma Ltd stock priceSwing Trading Ideas & Affordable Growth Trading - earlytimes.in

Nov 21, 2025
pulisher
Nov 21, 2025

Why Medicus Pharma Ltd. Equity Warrant stock remains on watchlistsQuarterly Trade Summary & Verified Short-Term Plans - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights - Livingston Daily

Nov 21, 2025
pulisher
Nov 20, 2025

Is Medicus Pharma Ltd. (N460) stock resilient in recession scenariosMarket Growth Summary & Growth-Oriented Investment Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Medicus Pharma Ltd. (N460) stock behaves under inflation pressure2025 Top Decliners & Technical Entry and Exit Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Medicus Pharma Ltd. stock benefit from commodity pricesJuly 2025 Momentum & AI Powered Buy and Sell Recommendations - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Medicus Pharma Ltd. (N460) stock gains from tech spendingJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Should I buy Medicus Pharma Ltd. (N460) stock before earnings seasonQuarterly Growth Report & High Accuracy Buy Signal Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How institutional buying supports Medicus Pharma Ltd. stock2025 Dividend Review & Fast Gaining Stock Strategy Reports - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 21:17:51 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 19:51:38 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How strong is Medicus Pharma Ltd. Equity Warrant stock revenue growth - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How big funds are accumulating Medicus Pharma Ltd. (N460) stockPortfolio Risk Report & Safe Entry Zone Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Medicus Pharma Ltd. stock maintain operating marginsSwing Trade & Reliable Intraday Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Medicus Pharma Ltd. (N460) stock a fit for income portfoliosJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Medicus Pharma Ltd. stock maintain growth trajectory - newser.com

Nov 19, 2025
drug_manufacturers_general SNY
$50.05
price down icon 0.46%
drug_manufacturers_general PFE
$25.77
price up icon 0.15%
$127.08
price up icon 0.07%
drug_manufacturers_general NVO
$48.56
price up icon 3.18%
$342.73
price up icon 0.46%
drug_manufacturers_general MRK
$105.37
price down icon 0.35%
Kapitalisierung:     |  Volumen (24h):